Delivery Order SPE2DB24D1006-SPE2DB25FCEXY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Lispro 100 Unit/mL pen 3mL vials, with a ceiling value of $1,292.88. This non-set-aside contract employs firm fixed price terms with an ultimate completion date of September 29, 2025. The order represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December...
- The Defense Logistics Agency awarded a $1,005.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Insulin Lispro 100 Unit/ML vials (10 ml) on September 23, 2025, with a completion date of September 24, 2025. The award was not set-aside and represents a competitively awarded delivery order under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency Troop Support Medical awarded a $182 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 unit/ml pens of insulin lispro in 3ml quantities. As the prime contractor, Amerisourcebergen Drug Corp will fulfill the order from its facility in Conshohocken, Pennsylvania under a one-day period of performance concluding on July 11, 2023. The delivery order was issued against the parent company Amerisourcebergen Corporation's...
- The Defense Logistics Agency awarded a $109,380 firm fixed price delivery order to Amerisourcebergen Drug Corporation for insulin lispro pen injectors. As the prime contractor, Amerisourcebergen will supply 3mL insulin lispro pens to support the Department of Defense's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. The delivery order was issued under an existing DLA pharmaceuticals contract...
- The Defense Logistics Agency awarded a $72,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for insulin lispro pen injectors. Under this order, Amerisourcebergen will provide 3mL insulin lispro pens to support the Department of Defense's medical supply needs. The delivery location is Amerisourcebergen's facility in Conshohocken, Pennsylvania. Performance is required from July 24-25, 2023. No subcontractors or set aside designations were specified. This order was placed...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $945 to Amerisourcebergen Drug Corporation to provide 100 unit/mL pens of insulin lispro in 3mL quantities. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products under the contract from its facility in Conshohocken, Pennsylvania by July 20, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Lispro 100 Unit/mL Pen 3mL at a firm fixed price of $1,036.86. The contract has a period of performance through March 12, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- The Defense Logistics Agency awarded a $16,119.96 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 8, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $1,069.96 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company...
- The Defense Logistics Agency awarded a $4,992.08 delivery order to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 17, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCEXYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,215.14 to AmerisourceBergen Drug Corp for Insulin Lispro 100 Unit/mL pen 3mL on July 24, 2025, with completion scheduled for July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health System and other government healthcare organizations. This delivery order represents a routine pharmaceutical supply transaction under the company's comprehensive IDC, which enables the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs globally. The contract reflects DLA's ongoing reliance on established pharmaceutical vendors through competitive procurement mechanisms to fulfill medical supply needs for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/24/25 |